Logo image of SQL

SEQLL INC (SQL) Stock Fundamental Analysis

NASDAQ:SQL - Nasdaq - US81734C3043 - Common Stock - Currency: USD

6.5991  -1.67 (-20.2%)

After market: 4.9999 -1.6 (-24.23%)

Fundamental Rating

2

Taking everything into account, SQL scores 2 out of 10 in our fundamental rating. SQL was compared to 55 industry peers in the Life Sciences Tools & Services industry. SQL may be in some trouble as it scores bad on both profitability and health. SQL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SQL had negative earnings in the past year.
In the past year SQL has reported a negative cash flow from operations.
SQL had negative earnings in each of the past 5 years.
In the past 5 years SQL always reported negative operating cash flow.
SQL Yearly Net Income VS EBIT VS OCF VS FCFSQL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -1M -2M -3M -4M

1.2 Ratios

SQL's Return On Assets of -79.09% is on the low side compared to the rest of the industry. SQL is outperformed by 91.80% of its industry peers.
SQL has a worse Return On Equity (-181.20%) than 90.16% of its industry peers.
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROIC N/A
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQL Yearly ROA, ROE, ROICSQL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 -500

1.3 Margins

SQL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SQL Yearly Profit, Operating, Gross MarginsSQL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -1K -2K -3K -4K -5K

More info and screens

3

2. Health

2.1 Basic Checks

SQL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQL remains at a similar level compared to 1 year ago.
SQL has a worse debt/assets ratio than last year.
SQL Yearly Shares OutstandingSQL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M
SQL Yearly Total Debt VS Total AssetsSQL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -6.09, we must say that SQL is in the distress zone and has some risk of bankruptcy.
SQL has a worse Altman-Z score (-6.09) than 91.80% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that SQL is somewhat dependend on debt financing.
The Debt to Equity ratio of SQL (0.50) is worse than 73.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z -6.09
ROIC/WACCN/A
WACC11.75%
SQL Yearly LT Debt VS Equity VS FCFSQL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 2M -2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 5.04 indicates that SQL has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.04, SQL is in the better half of the industry, outperforming 70.49% of the companies in the same industry.
SQL has a Quick Ratio of 5.04. This indicates that SQL is financially healthy and has no problem in meeting its short term obligations.
SQL has a better Quick ratio (5.04) than 75.41% of its industry peers.
Industry RankSector Rank
Current Ratio 5.04
Quick Ratio 5.04
SQL Yearly Current Assets VS Current LiabilitesSQL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

4

3. Growth

3.1 Past

SQL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3588.50%.
SQL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
The Revenue for SQL have been decreasing by -43.28% on average. This is quite bad
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%

3.2 Future

SQL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.17% yearly.
SQL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 354.84% yearly.
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SQL Yearly Revenue VS EstimatesSQL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2025 2M 4M 6M
SQL Yearly EPS VS EstimatesSQL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SQL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SQL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SQL Price Earnings VS Forward Price EarningsSQL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQL Per share dataSQL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

SQL's earnings are expected to grow with 25.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.64%
EPS Next 3Y25.17%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SQL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQLL INC

NASDAQ:SQL (11/13/2023, 8:16:47 PM)

After market: 4.9999 -1.6 (-24.23%)

6.5991

-1.67 (-20.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-16 2023-03-16/amc
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner Change-99.58%
Ins Owners6727.96%
Ins Owner Change0%
Market Cap2.51M
Analysts80
Price Target3.06 (-53.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-13.6
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-12.25
FCFYN/A
OCF(TTM)-12.06
OCFYN/A
SpS0
BVpS7.67
TBVpS7.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -79.09%
ROE -181.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-78.44%
ROA(5y)-151.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 58.35%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.04
Quick Ratio 5.04
Altman-Z -6.09
F-Score1
WACC11.75%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3588.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4718.47%
EPS Next Y96.95%
EPS Next 2Y39.64%
EPS Next 3Y25.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3Y-47.05%
Revenue growth 5Y-43.28%
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y354.84%
Revenue Next 5YN/A
EBIT growth 1Y-48.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.06%
OCF growth 3YN/A
OCF growth 5YN/A